|
|
Volumn 1, Issue 4, 2010, Pages
|
|
Bcl-2 antagonists and cancer: From the clinic, back to the bench
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 [4 (4' CHLORO 2 BIPHENYLYLMETHYL) 1 PIPERAZINYL] N [4 [3 DIMETHYLAMINO 1 (PHENYLTHIOMETHYL)PROPYLAMINO] 3 NITROBENZENESULFONYL]BENZAMIDE;
ANTINEOPLASTIC AGENT;
PROTEIN BAD;
PROTEIN BCL 2;
PROTEIN BID;
APOPTOSIS;
CELL DEATH;
CELL INTERACTION;
CELL PERMEABILIZATION;
CONFERENCE PAPER;
DRUG PROTEIN BINDING;
DRUG STRUCTURE;
HUMAN;
MITOCHONDRIAL MEMBRANE;
NEOPLASM;
OUTPATIENT DEPARTMENT;
PRIORITY JOURNAL;
PROTEIN LIPID INTERACTION;
|
|
EID: 79960022659
PISSN: None
EISSN: 20414889
Source Type: Journal
DOI: 10.1038/cddis.2010.15 Document Type: Conference Paper |
|
Times cited : (10)
|
|
References (0)
|
